Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model.
Barsheshet Y, Voloshin T, Brant B, Cohen G, Koren L, Blatt R, Cahal S, Haj Khalil T, Zemer Tov E, Paz R, Klein-Goldberg A, Tempel-Brami C, Jacobovitch S, Volodin A, Kan T, Koltun B, David C, Haber A, Giladi M, Weinberg U, Palti Y.
Barsheshet Y, et al. Among authors: blatt r.
Int J Mol Sci. 2022 Nov 15;23(22):14073. doi: 10.3390/ijms232214073.
Int J Mol Sci. 2022.
PMID: 36430552
Free PMC article.